推进阿尔茨海默氏症治疗:计算策略和治疗创新
Jibon Kumar Paul1, Abbeha Malik2, Mahir Azmal1
1Department of Biochemistry and Molecular Biology, Shahjalal University of Science and Technology, Sylhet 3114, Bangladesh.
IBRO neuroscience reports
|February 25, 2025
概括
计算方法为阿尔茨海默病 (AD) 治疗提供了新的希望,通过改善药物发现和实现个性化医疗. 这些先进的技术有助于确定目标并预测治疗疗效,以获得更好的患者结果.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种复杂的神经退行性疾病,有效治疗方法有限,需要新的治疗策略.
- 目前的治疗方法主要是治疗症状,这强调了需要解决疾病机制的方法.
- 对阿尔茨海默病的常规药物发现面临着重大挑战和局限性.
研究的目的:
- 审查阿尔茨海默病治疗中的挑战.
- 探索计算方法的整合,以推进阿尔茨海默病的治疗干预措施.
- 突出计算方法在药物发现和AD个性化医学的潜力.
主要方法:
- 对阿尔茨海默病病因和当前治疗局限性的综合文献分析.
- 审查用于阐明疾病机制和确定治疗点的计算模型.
- 检查机器学习算法用于早期诊断和精准医学在AD.
主要成果:
- 计算模型对于预测药物疗效,优化化合物和个性化AD治疗至关重要.
- 机器学习通过多模式数据分析增强了早期AD诊断和精准医学.
- 案例研究表明,计算机技术可以抑制关键蛋白质并重新定位阿尔茨海默病的药物.
结论:
- 计算方法代表了阿尔茨海默氏症治疗方法的范式转变,提供了创新的解决方案.
- 整合计算方法可以克服现有的治疗挑战,改善患者的治疗结果.
- 计算生物学家,药理学家和临床医生之间的合作对于将计算见解转化为临床实践至关重要.
相关概念视频
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:30Dementia
693
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
693
01:29Alzheimer Disease l: Introduction
29
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29
01:23Alzheimer Disease ll: Pathophysiology
42
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35